NEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N-terminal 251 residues are sufficient for this process.
about
Azidothymidine Sensitizes Primary Effusion Lymphoma Cells to Kaposi Sarcoma-Associated Herpesvirus-Specific CD4+ T Cell Control and Inhibits vIRF3 FunctionProbing the Solution Structure of IκB Kinase (IKK) Subunit γ and Its Interaction with Kaposi Sarcoma-associated Herpes Virus Flice-interacting Protein and IKK Subunit β by EPR SpectroscopyInterplay between Kaposi's sarcoma-associated herpesvirus and the innate immune system.Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.Distinct Activation Mechanisms of NF-κB Regulator Inhibitor of NF-κB Kinase (IKK) by Isoforms of the Cell Death Regulator Cellular FLICE-like Inhibitory Protein (cFLIP).Immune control of oncogenic γ-herpesviruses.Diverse mechanisms evolved by DNA viruses to inhibit early host defenses.IKKγ-Mimetic Peptides Block the Resistance to Apoptosis Associated with Kaposi's Sarcoma-Associated Herpesvirus Infection.Development and characterization of a novel luciferase based cytotoxicity assay.CADM1 is essential for KSHV-encoded vGPCR-and vFLIP-mediated chronic NF-κB activation.Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
P2860
Q28554487-E0384BF9-D8F6-47FA-8D00-CBD2239330B0Q30374718-CA633EAC-5E25-471A-9A5A-4303BB2D289BQ34615002-9AF4474F-A2E7-48B5-A8BF-C3C227ABD0C8Q35801267-0B6A8692-54D8-4500-BA34-8A6F71FE2C74Q36755072-B2A0E9A4-2FA0-43AC-B343-0F2C2B8D2623Q38587362-BE959ACD-C180-4B85-A283-55D749DD6879Q38960064-93ECB737-D4F5-4E5A-91DE-32CEA85E4312Q41933434-599542B0-EF33-4E02-B586-5F5779F9DDC4Q48276267-2A7100F0-CE5C-4E4F-9680-B69932B6AF2FQ52308826-84394181-D441-439F-8933-D6B3DA99C201Q58778363-340F4332-27C6-4430-9A9D-9DB71E690081
P2860
NEMO is essential for Kaposi's sarcoma-associated herpesvirus-encoded vFLIP K13-induced gene expression and protection against death receptor-induced cell death, and its N-terminal 251 residues are sufficient for this process.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
NEMO is essential for Kaposi's ...... e sufficient for this process.
@ast
NEMO is essential for Kaposi's ...... e sufficient for this process.
@en
type
label
NEMO is essential for Kaposi's ...... e sufficient for this process.
@ast
NEMO is essential for Kaposi's ...... e sufficient for this process.
@en
prefLabel
NEMO is essential for Kaposi's ...... e sufficient for this process.
@ast
NEMO is essential for Kaposi's ...... e sufficient for this process.
@en
P2093
P2860
P356
P1433
P1476
NEMO is essential for Kaposi's ...... re sufficient for this process
@en
P2093
Bhairavi Tolani
Hittu Matta
Preet M Chaudhary
P2860
P304
P356
10.1128/JVI.00028-14
P577
2014-03-26T00:00:00Z